Safety and immunopotency of an adenovirus-vectored tuberculosis vaccine delivered via inhaled aerosol to healthy humans: a dose and route comparison phase 1b study
Mangalakumari Jeyanathan, Dominik K. Fritz, Sam Afkhami, Emilio Aguirre, Karen J. Howie, Anna Zganiacz, Anna Dvorkin-Gheva, Michael R. Thompson, Richard F. Silver, Ruth P. Cusack, Brian D. Lichty, Paul M. O’Byrne, Martin Kolb, Maria Fe C. Medina, Myrna B. Dolovich, Imran Satia, Gail M. Gauvreau, Zhou Xing, Fiona Smaill
doi: https://doi.org/10.1101/2021.09.09.21263339
Mangalakumari Jeyanathan
1McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada
2M. G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada
3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Dominik K. Fritz
1McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada
2M. G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada
3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Sam Afkhami
1McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada
2M. G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada
3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Emilio Aguirre
4Department of Pathology & Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
Karen J. Howie
3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Anna Zganiacz
1McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada
2M. G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada
3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Anna Dvorkin-Gheva
1McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada
3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Michael R. Thompson
5Department of Chemical Engineering, McMaster University, Hamilton, Ontario, Canada
Richard F. Silver
6Department of Critical Care and Sleep Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
Ruth P. Cusack
3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Brian D. Lichty
1McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada
3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Paul M. O’Byrne
3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Martin Kolb
3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Maria Fe C. Medina
1McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada
3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Myrna B. Dolovich
3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Imran Satia
3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Gail M. Gauvreau
3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Zhou Xing
1McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada
2M. G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada
3Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Fiona Smaill
2M. G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada
4Department of Pathology & Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
Data Availability
All data related to this clinical vaccine trial will be made available
Posted September 14, 2021.
Safety and immunopotency of an adenovirus-vectored tuberculosis vaccine delivered via inhaled aerosol to healthy humans: a dose and route comparison phase 1b study
Mangalakumari Jeyanathan, Dominik K. Fritz, Sam Afkhami, Emilio Aguirre, Karen J. Howie, Anna Zganiacz, Anna Dvorkin-Gheva, Michael R. Thompson, Richard F. Silver, Ruth P. Cusack, Brian D. Lichty, Paul M. O’Byrne, Martin Kolb, Maria Fe C. Medina, Myrna B. Dolovich, Imran Satia, Gail M. Gauvreau, Zhou Xing, Fiona Smaill
medRxiv 2021.09.09.21263339; doi: https://doi.org/10.1101/2021.09.09.21263339
Safety and immunopotency of an adenovirus-vectored tuberculosis vaccine delivered via inhaled aerosol to healthy humans: a dose and route comparison phase 1b study
Mangalakumari Jeyanathan, Dominik K. Fritz, Sam Afkhami, Emilio Aguirre, Karen J. Howie, Anna Zganiacz, Anna Dvorkin-Gheva, Michael R. Thompson, Richard F. Silver, Ruth P. Cusack, Brian D. Lichty, Paul M. O’Byrne, Martin Kolb, Maria Fe C. Medina, Myrna B. Dolovich, Imran Satia, Gail M. Gauvreau, Zhou Xing, Fiona Smaill
medRxiv 2021.09.09.21263339; doi: https://doi.org/10.1101/2021.09.09.21263339
Subject Area
Subject Areas
- Addiction Medicine (361)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2709)
- Dermatology (232)
- Emergency Medicine (409)
- Epidemiology (12351)
- Forensic Medicine (10)
- Gastroenterology (778)
- Genetic and Genomic Medicine (4201)
- Geriatric Medicine (394)
- Health Economics (693)
- Health Informatics (2714)
- Health Policy (1012)
- Hematology (366)
- HIV/AIDS (871)
- Medical Education (402)
- Medical Ethics (111)
- Nephrology (447)
- Neurology (3983)
- Nursing (216)
- Nutrition (588)
- Oncology (2099)
- Ophthalmology (598)
- Orthopedics (249)
- Otolaryngology (309)
- Pain Medicine (254)
- Palliative Medicine (77)
- Pathology (474)
- Pediatrics (1138)
- Primary Care Research (464)
- Public and Global Health (6609)
- Radiology and Imaging (1432)
- Respiratory Medicine (879)
- Rheumatology (417)
- Sports Medicine (348)
- Surgery (458)
- Toxicology (57)
- Transplantation (192)
- Urology (170)